Editorial : Molecular targets for anticancer drug discovery and development

Ntwasa, Monde; Dlamini, Zodwa

dc.contributor.author	Ntwasa, Monde
dc.contributor.author	Dlamini, Zodwa
dc.date.accessioned	2024-12-04T12:30:44Z
dc.date.available	2024-12-04T12:30:44Z
dc.date.issued	2024-04
dc.description.abstract	No abstract available.	en_US
dc.description.department	Medical Oncology	en_US
dc.description.sdg	SDG-03:Good heatlh and well-being	en_US
dc.description.sponsorship	The South African Medical Research Council (SAMRC), and the National Research Foundation (NRF).	en_US
dc.description.uri	https://www.frontiersin.org/journals/genetics	en_US
dc.identifier.citation	Ntwasa, M. & Dlamini, Z. (2024), Editorial: Molecular targets for anticancer drug discovery and development. Frontiers in Genetics 15:1374867. doi: 10.3389/fgene.2024.1374867.	en_US
dc.identifier.issn	1664-8021 (online)
dc.identifier.other	10.3389/fgene.2024.1374867
dc.identifier.uri	http://hdl.handle.net/2263/99767
dc.language.iso	en	en_US
dc.publisher	Frontiers Media	en_US
dc.rights	© 2024 Ntwasa and Dlamini. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY).	en_US
dc.subject	Small molecule anticancer drugs	en_US
dc.subject	Molecularly targeted therapies	en_US
dc.subject	Pharmacogenetics	en_US
dc.subject	Model organisms (Drosophila)	en_US
dc.subject	Drug repurposing	en_US
dc.subject	SDG-03: Good health and well-being	en_US
dc.subject	Editorial	en_US
dc.title	Editorial : Molecular targets for anticancer drug discovery and development	en_US
dc.type	Article	en_US